Prescribing with indication: Uptake of regulations in current practice and patients opinions in the Netherlands

International Journal of Clinical Pharmacy

Volumn 36, Issue 2, 2014, Pages 282-286

  Holsappel, Inge G A ^a   Koster, Ellen S ^a   Winters, Nina A ^a   Bouvy, Marcel L ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Community pharmacy; Medication safety; Medicines act; Prescribing indication; Prescription; The Netherlands

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ALBENDAZOLE; AMANTADINE; AMITRIPTYLINE; CARBAMAZEPINE; CHLOROQUINE; CIMETIDINE; ESOMEPRAZOLE; ESTRADIOL; FLUCONAZOLE; FOLIC ACID; GABAPENTIN; HALOPERIDOL; HEXAMETHONIUM BROMIDE; HYDROXYCHLOROQUINE; IMIPRAMINE; ITRACONAZOLE; LANSOPRAZOLE; MEBENDAZOLE; METHADONE; METRONIDAZOLE; MINOCYCLINE; NIZATIDINE; NORFLOXACIN; NORTRIPTYLINE; OMEPRAZOLE; PANTOPRAZOLE; PHENYTOIN; UNINDEXED DRUG;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG INDICATION; FEMALE; GENERAL PRACTITIONER; HEALTH CARE POLICY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; NETHERLANDS; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; COUNSELING; LEGISLATION AND JURISPRUDENCE; MEDICATION ERROR; PHARMACY; PREVENTION AND CONTROL;

COMMUNITY PHARMACY SERVICES; COUNSELING; DRUG PRESCRIPTIONS; FEMALE; GENERAL PRACTITIONERS; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; NETHERLANDS;

EID: 84899934359     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9903-8     Document Type: Article

References (13)

1. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the netherlands. Arch Intern Med. 2008;168(17):1890-6.
2. de Las Mercedes Martinez Sanchez A. Medication errors in a spanish community pharmacy: nature, frequency and potential causes. Int J Clin Pharm. 2013;35(2):185-9.
3. Moore TJ, Walsh CS, Cohen MR. Reported medication errors associated with methotrexate. Am J Health Syst Pharm. 2004; 61(13):1380-4. (Pubitemid 39481445)
4. De Minister van Volksgezondheid,Welzijn en Sport, E.I. Schippers. Regeling Geneesmiddelenwet, Bijlage 1 [Dutch Medicines Act, Appendix 1]. http://wetten.overheid.nl/BWBR0022160 Accessed 18 Sept 2013.
5. Folmer H, de Leest K, Grandia L, Njoo KH. Voorstel standaardlijst van geneesmiddel&reden van voorschrijven. [Proposal standard list medicines&indication for prescription]. 2008. http://www.nictiz.nl/page/ Publicaties?mod[360][i]=158&mod[360][search-type]=title&mod[360] [search-for]=oorstel%20standaardlijst. Accessed 18 Sept 2013.
6. Hofmans-Okkes IM, Lamberts H. The international classification of primary care (ICPC): new applications in research and computer-based patient records in family practice. Fam Pract. 1996; 13(3):294-302. (Pubitemid 26229398)
7. Okkes I, Jamoulle M, Lamberts H, Bentzen N. ICPC-2-E: the electronic version of ICPC-2. differences from the printed version and the consequences. Fam Pract. 2000;17(2):101-7. (Pubitemid 30201049)
8. SFK. Data en feiten (2012) Het jaar 2011 in cijfers. [Facts and Figures 2012: 2011 in numbers]. Stichting FarmaceutischeKengetallen. August 2012.Available through: http://www.sfk.nl/pdf-documenten/data-en-feiten/data-en- feiten-2012 Accessed 18 Sept 2013.
9. Al-Arifi MN. Patients' perception, views and satisfaction with pharmacists' role as health care provider in community pharmacy setting at riyadh, saudi arabia. Saudi Pharm J. 2012;20(4):323-30.
10. McAuley JW, Miller MA, Klatte E, Shneker BF. Patients with epilepsy's perception on community pharmacist's current and potential role in their care. Epilepsy Behav. 2009;14(1):141-5.
11. Lewis RQ, Fletcher M. Implementing a national strategy for patient safety: lessons from the national health service in england. Qual Saf Health Care. 2005;14(2):135-9. (Pubitemid 40523859)
12. Kaplan HC, Brady PW, Dritz MC, et al. The influence of context on quality improvement success in health care: a systematic review of the literature. Milbank Q. 2010;88(4):500-59.
13. de Jong J, Visser MR, Wieringa-de Waard M. Which barriers affect morbidity registration performance of GP trainees and trainers? Int J Med Inform. 2013;82(8):708-16.